12-55726691-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001780.6(CD63):c.426+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 1,609,206 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0089 ( 16 hom., cov: 31)
Exomes 𝑓: 0.00087 ( 21 hom. )
Consequence
CD63
NM_001780.6 intron
NM_001780.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.103
Genes affected
CD63 (HGNC:1692): (CD63 molecule) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. The encoded protein is a cell surface glycoprotein that is known to complex with integrins. It may function as a blood platelet activation marker. Deficiency of this protein is associated with Hermansky-Pudlak syndrome. Also this gene has been associated with tumor progression. Alternative splicing results in multiple transcript variants encoding different protein isoforms. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 12-55726691-C-G is Benign according to our data. Variant chr12-55726691-C-G is described in ClinVar as [Benign]. Clinvar id is 709893.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00892 (1358/152226) while in subpopulation AFR AF= 0.0308 (1280/41534). AF 95% confidence interval is 0.0294. There are 16 homozygotes in gnomad4. There are 635 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 16 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD63 | NM_001780.6 | c.426+9G>C | intron_variant | ENST00000257857.9 | NP_001771.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD63 | ENST00000257857.9 | c.426+9G>C | intron_variant | 1 | NM_001780.6 | ENSP00000257857.4 | ||||
CD63 | ENST00000552067.5 | c.147+9G>C | intron_variant | 5 | ENSP00000449684.1 | |||||
CD63 | ENST00000550050.5 | n.*92+9G>C | intron_variant | 5 | ENSP00000449435.1 |
Frequencies
GnomAD3 genomes AF: 0.00893 AC: 1359AN: 152108Hom.: 16 Cov.: 31
GnomAD3 genomes
AF:
AC:
1359
AN:
152108
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00222 AC: 558AN: 251406Hom.: 9 AF XY: 0.00166 AC XY: 226AN XY: 135872
GnomAD3 exomes
AF:
AC:
558
AN:
251406
Hom.:
AF XY:
AC XY:
226
AN XY:
135872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000874 AC: 1274AN: 1456980Hom.: 21 Cov.: 30 AF XY: 0.000775 AC XY: 562AN XY: 725258
GnomAD4 exome
AF:
AC:
1274
AN:
1456980
Hom.:
Cov.:
30
AF XY:
AC XY:
562
AN XY:
725258
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00892 AC: 1358AN: 152226Hom.: 16 Cov.: 31 AF XY: 0.00853 AC XY: 635AN XY: 74426
GnomAD4 genome
AF:
AC:
1358
AN:
152226
Hom.:
Cov.:
31
AF XY:
AC XY:
635
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at